DEA Schedule I

DEA Issues Order to Ban Mitragynine Pseudoindoxyl, MGM-15, and MGM-16

On August 24 the DEA announced an order to place mitragynine pseudoindoxyl, MGM-15, and MGM-16 on Schedule I of the federal list of controlled substances for a period of two years. The announcement in part said: The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and …

DEA Issues Order to Ban Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 Read More »

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition

Tonight at 11:59 PM, the Department of Health and Human Services (HHS) will close comments on the notice “Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information“. The notice asks for specific information and scientific evidence about the threshold of 7-OH that should be allowable in kratom products. However, many …

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition Read More »

DEA Announces Temporary 7-OH Ban; Public Comment Period Underway

On July 6, the United States Drug Enforcement Agency (DEA) published a notice in the Federal Register that it intends to place 7-hydroxymitragynine (7-OH) on Schedule I of the Controlled Substances Act. This is an emergency rule that would temporarily place covered 7-OH products in Schedule I for up to two years while the DEA …

DEA Announces Temporary 7-OH Ban; Public Comment Period Underway Read More »